Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
AstraZeneca speeds R&D decision making with cutting-edge life sciences technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
The new applications represent the initial output in an ongoing partnership between Thomson Reuters and AstraZeneca, with other applications due to be released this year. The Thomson Reuters Life Sciences Professional Services team is working on similar innovative projects for other customers too.
Launched in late 2011, Cortellis is the most powerful tool of its kind for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development. For more information on the oncology decision support dashboards and Cortellis, go to http://cortellis.thomsonreuters.com/.
0 Comments
View Comments
- People:
- Wendy Hamilton
- Places:
- PHILADELPHIA, PA
Press Release
Author's page
Related Content
Comments